BALTIMORE--(BUSINESS WIRE)--Cerecor Inc. (NASDAQ:CERC), a clinical-stage biopharmaceutical company developing treatments to make a difference in the lives of patients with neurological and psychiatric disorders, today announced that it will host its first Research & Development Day in New York City on March 1, 2016, starting at 8:30 a.m. EST. Invited experts will discuss the current therapy landscape as well as novel approaches for treatment of depression and substance use.
